Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

June 20, 2014

OTSUKA PHARMACEUTICAL CO., LTD. v. INTAS PHARMACEUTICALS LIMITED et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. June 25, 2014

    Otsuka Sues To Block Intas' Generic Abilify

    Otsuka Pharmaceutical Co. Ltd. has sued Intas Pharmaceuticals Ltd. and its subsidiaries in New Jersey federal court for allegedly infringing its patent on the widely prescribed antipsychotic medication Abilify, after an Intas subsidiary announced plans to begin manufacturing a generic version of the drug.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login